Mossrock Capital
2
80M
2
2
- Areas of investment
Summary
The company was established in North America in United States. The main department of described VC is located in the Englewood.
Besides them, we counted 1 critical employee of this fund in our database.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the Mossrock Capital, startups are often financed by Vivo Capital, Sofinnova Investments, F-Prime Capital. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Sofinnova Investments, Rock Springs Capital. In the next rounds fund is usually obtained by Aisling Capital.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Therapeutics, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Aclaris Therapeutics.
The higher amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 2
- Investments by industry
- Pharmaceutical (2)
- Biotechnology (2)
- Drug Discovery (1)
- Pharmaceuticals (1)
- Therapeutics (1) Show 4 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
- Avg. company exit year
- 22
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| SomaLogic | 25 Nov 2020 | Biotechnology, Health Care, Health Diagnostics, Medical Device, Life Science, Pharmaceutical | Early Stage Venture | 121M | United States, Boulder, Colorado |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.